Rob Matheis reveals how better alignment and communication are the keys to unlocking oncology’s scientific potential for real patient impact.
How do we ensure groundbreaking oncology science reaches and benefits patients in the real world?
Join Dr. Kirk Shepard as he sits down with Rob Matheis, President and CEO of ISMPP, for a pinpoint discussion about the hidden breakdowns in cancer drug development. They cut through the complexity to expose why generating evidence is just the beginning—and why fragmented communication can derail even the best science.
In this episode of the Oncology Voice Network podcast, you’ll learn why alignment—not just data—is oncology’s toughest challenge, how nuanced scientific details often get lost between teams, and the risks of conflicting interpretations and digital noise in the AI era. They dive into practical steps to foster collaboration and shared understanding, while exploring the evolving role of medical communications in the next decade of cancer care.
Packed with real-world insights and bold suggestions, this episode is a must-listen for anyone passionate about making advanced oncology science truly actionable for patients.
Listen now and join the voices shaping the future of cancer care.
Follow Us
Presented by Oncology Voice Network
www.oncologyvoicenetwork.com